1. Introduction

Vaccine tender bid rigging is a serious form of anti-competitive conduct in which pharmaceutical manufacturers, vaccine suppliers, distributors, wholesalers or other market participants secretly coordinate their bids to manipulate the outcome of public procurement procedures.

In Morocco, vaccine procurement is particularly important because vaccines are essential public-health products. Government authorities, public hospitals, healthcare institutions and procurement agencies must obtain vaccines at competitive prices while ensuring quality, safety, timely delivery and continuity of supply.

Bid rigging undermines these objectives by artificially increasing procurement costs, restricting supplier participation, allocating contracts among competitors and reducing incentives to provide better products or services.

The central legal framework is Moroccan Law No. 104-12 on Freedom of Prices and Competition, particularly Article 6, which prohibits agreements and concerted practices that restrict competition, including arrangements to allocate public contracts. Article 7 addresses abuse of dominant position.

WIPO Lex+1

An important distinction: the cases discussed below are comparative judicial precedents illustrating the application of competition-law principles. They should not be represented as six Moroccan judgments specifically concerning vaccine tender collusion.

2. Legal Framework Governing Vaccine Tender Bid Rigging in Morocco

A. Law No. 104-12 on Freedom of Prices and Competition

Article 6 prohibits express or tacit agreements, concerted practices and coalitions that prevent, restrict or distort competition.

In vaccine procurement, prohibited conduct may include:

Agreements between pharmaceutical companies to submit artificially high bids.

Agreements to divide vaccine procurement contracts between suppliers.

Agreements to rotate winning positions across successive tenders.

Agreements to withdraw or deliberately weaken competing bids.

Agreements to manipulate vaccine distribution territories.

Agreements to restrict supplies to public healthcare institutions.

The prohibition applies to conduct affecting competition in the Moroccan market, including conduct by foreign undertakings where the relevant effects arise in Morocco.

B. Article 7: Abuse of Dominant Position

Article 7 becomes relevant where a vaccine manufacturer or distributor holds a dominant position and abuses that position.

Examples include:

Refusing to supply vaccines without legitimate justification.

Imposing discriminatory commercial conditions.

Making access to one essential vaccine conditional on purchasing another product.

Excluding competing distributors through restrictive arrangements.

Exploiting dependence where public or private buyers have no equivalent alternative.

Dominance alone is not unlawful. The prohibited element is its abusive exploitation.

C. Article 9: Exemptions

Article 9 provides for limited exemptions where agreements satisfy statutory conditions, including economic or technical progress and benefits to users, while preserving the necessary restrictions and competition.

However, ordinary price-fixing and tender allocation cannot be justified merely by claiming that cooperation improves commercial efficiency.

D. Public Procurement Decree No. 2-22-431 of 8 March 2023

Morocco's public procurement framework complements competition law.

Relevant provisions include:

Article 160: Professional secrecy.

Article 161: Confidentiality of procurement procedures.

Article 162: Combating fraud, corruption and conflicts of interest.

Article 163: Complaints by competing bidders concerning procurement irregularities.

These provisions are particularly relevant where procurement officials, pharmaceutical suppliers or tender committee members participate in arrangements that compromise procurement independence.

tgr.gov.ma+1

3. Forms of Vaccine Tender Bid Rigging

A. Bid Rotation

Bid rotation occurs when competing pharmaceutical suppliers agree to take turns winning government vaccine contracts.

For example:

Supplier A wins the first vaccine tender.

Supplier B wins the second tender.

Supplier C wins the third tender.

The remaining suppliers submit deliberately uncompetitive bids.

Although different companies appear to compete, the actual outcome has already been determined.

Legal significance: This may constitute market allocation and collusion under Article 6 of Law No. 104-12.

B. Cover Bidding

Cover bidding occurs when competing companies submit deliberately high, incomplete or commercially unattractive bids to make the selected supplier appear to be the most competitive bidder.

For example, three vaccine distributors agree that Supplier A will win a tender for 500,000 vaccine doses. Suppliers B and C submit inflated prices to create an appearance of competition.

This practice undermines the genuine competitive nature of public procurement.

C. Price Fixing

Price fixing involves agreements between vaccine suppliers concerning:

Minimum tender prices.

Maximum discounts.

Transportation charges.

Distribution margins.

Cold-chain management costs.

Payment conditions.

Competitors must independently determine their commercial offers. An agreement to eliminate price competition may violate Article 6.

D. Market Allocation

Suppliers may divide vaccine procurement according to:

Geographic regions.

Public hospitals.

Government healthcare agencies.

Vaccine categories.

Procurement periods.

Contract quantities.

For instance, two pharmaceutical distributors may agree that one will supply vaccines to hospitals in Casablanca while the other supplies hospitals in Rabat.

Such arrangements may amount to prohibited allocation of public contracts.

E. Bid Suppression

Bid suppression occurs when one supplier agrees not to participate in a tender or withdraws its bid to facilitate another supplier's victory.

This can involve financial compensation, reciprocal promises or future contract allocation.

F. Information Exchange

Competitors may exchange confidential information concerning:

Intended bid prices.

Available vaccine quantities.

Production capacity.

Delivery schedules.

Discounts and rebates.

Tender participation strategies.

Not every exchange of information is unlawful. However, exchanges that eliminate strategic uncertainty and facilitate coordinated bidding can constitute prohibited concerted practices.

4. Relevant Market Definition

Market definition is essential when investigating vaccine tender collusion.

A. Product market

The relevant market may be defined according to the specific vaccine and its therapeutic or preventive purpose.

Examples include:

COVID-19 vaccines.

Influenza vaccines.

Hepatitis vaccines.

Human papillomavirus vaccines.

Childhood immunisation vaccines.

Other specialised vaccines.

Different vaccines cannot automatically be treated as substitutes because they may protect against different diseases and have different regulatory approvals.

B. Geographic market

The relevant geographic market may be:

National: vaccine procurement throughout Morocco.

Regional: procurement in particular regions.

Institutional: procurement by a specific public healthcare authority, where the competitive conditions justify such a distinction.

The geographic market depends on procurement arrangements, regulatory requirements, transportation conditions, supplier availability and the ability of buyers to obtain equivalent products from other locations.

C. Relevant market factors

Investigators should examine:

Number of qualified manufacturers.

Market shares of vaccine suppliers.

Regulatory authorisations.

Import requirements.

Distribution capacity.

Cold-chain infrastructure.

Availability of alternative vaccines.

Production and delivery constraints.

A small number of qualified manufacturers does not itself establish collusion. Independent conduct must be distinguished from coordinated behaviour.

5. Six Important Case Laws and Their Application

The following European Union judgments provide useful comparative principles for Moroccan competition-law analysis. They are not binding interpretations of Moroccan law, but their reasoning can help explain how competition authorities and courts assess cartel conduct.

Case 1: T-Mobile Netherlands BV and Others v Raad van bestuur van de Nederlandse Mededingingsautoriteit (2009)

Case C-8/08 · Court of Justice of the European Union

Principle: A single meeting may establish a concerted practice.

The dispute concerned competing telecommunications operators exchanging commercially sensitive information about dealer commissions.

The Court recognised that even a single meeting between competitors may constitute a concerted practice where the exchange has an anti-competitive object.

Application to Moroccan vaccine tenders:

If representatives of vaccine manufacturers meet once before a government tender and agree on:

Who should win the contract.

What prices should be submitted.

Which suppliers should withdraw.

How future tenders should be allocated.

The limited number of meetings would not automatically prevent a finding of collusion.

The important question is whether the evidence establishes unlawful coordination.

EUR-Lex+1

Case 2: Eturas UAB and Others v Lietuvos Respublikos konkurencijos taryba (2016)

Case C-74/14 · Court of Justice of the European Union

Principle: Electronic communications and circumstantial evidence can establish concerted practices.

The case concerned travel agencies using a common online booking system. A system administrator communicated a restriction on discounts through the platform.

The Court examined the evidential requirements for establishing whether businesses knew about and participated in the anti-competitive arrangement.

Application to Moroccan vaccine tenders:

Suppose pharmaceutical suppliers use a common digital procurement platform and exchange messages concerning:

Tender prices.

Winning suppliers.

Bid withdrawal.

Vaccine allocation.

Commercial discounts.

Electronic messages, platform records and communication histories may provide evidence of coordination.

However, the mere receipt of a communication is not automatically proof that every recipient participated in the cartel. Knowledge, involvement and the relevant evidential standard must be established.

EUR-Lex+1

Case 3: European Commission v Verhuizingen Coppens NV (2012)

Case C-441/11 P · Court of Justice of the European Union

Principle: Cover bidding and liability for cartel participation.

This case concerned a Belgian international removal-services cartel involving price agreements, customer allocation and manipulated tenders.

The cover-quote arrangement resulted in deliberately inflated bids that made the tender process appear competitive.

The Court considered the distinction between participation in an individual anti-competitive arrangement and responsibility for a broader cartel.

Application to Moroccan vaccine tenders:

If a vaccine supplier submits a deliberately inflated quotation to help another manufacturer win a procurement contract, this may constitute cover bidding.

However, investigators must establish the particular conduct attributable to each undertaking. Participation in one arrangement does not automatically establish responsibility for every other activity of the cartel.

This is especially important where manufacturers, importers and distributors operate through different commercial agreements.

EUR-Lex+1

Case 4: Commission v Anic Partecipazioni SpA (1999)

Case C-49/92 P · Court of Justice of the European Communities

Principle: Agreements and concerted practices may form part of a wider cartel.

The judgment is important for distinguishing formal agreements from coordinated conduct and for understanding participation in a broader anti-competitive arrangement.

Application to Moroccan vaccine tenders:

Vaccine companies do not necessarily need to sign a formal written agreement to engage in prohibited coordination.

Evidence may include:

Repeated communications.

Coordinated tender submissions.

Reciprocal allocation arrangements.

Deliberate withdrawal of competing bids.

Consistent implementation of an agreed strategy.

The Moroccan authority can examine the substance of the conduct rather than relying exclusively on whether a written contract exists.

Case 5: Aalborg Portland A/S and Others v Commission (2004)

Joined Cases C-204/00 P and others · Court of Justice of the European Union

Principle: Cartels may be established through a body of consistent circumstantial evidence.

The case concerned competition infringements in the cement industry and the assessment of evidence concerning cartel participation.

The Court addressed how meetings, contacts and other evidence can collectively establish anti-competitive coordination.

Application to Moroccan vaccine tenders:

A vaccine tender investigation may reveal:

Unusual similarities between bids.

Identical calculation errors.

Similar confidential wording.

Repeated patterns of bid withdrawal.

Unexplained price increases.

Communications between competing suppliers.

No single indicator necessarily proves collusion. However, several independent and consistent indicators may collectively support an infringement finding, provided plausible alternative explanations are properly considered.

Case 6: European Commission v Verhuizingen Coppens NV (2012) – Individual Participation and Attribution

Case C-441/11 P · Additional evidential application

Principle: Liability must be based on proven participation and knowledge.

A company cannot automatically be held responsible for every component of a wider cartel simply because it participated in one anti-competitive arrangement.

Application to Moroccan vaccine tenders:

Consider three participants:

Manufacturer A coordinates bid prices.

Distributor B submits a cover bid.

Distributor C independently supplies transportation services.

Their responsibilities must be examined individually.

If Distributor C merely provides legitimate logistics services without knowledge of or participation in the collusive arrangement, its involvement in the vaccine supply chain does not automatically establish cartel liability.

This distinction is important for ensuring fair enforcement and proportional sanctions.

EUR-Lex+1

Note on the case list: The sixth discussion develops a separate application of the same Coppens judgment, rather than introducing a different precedent. It is included to distinguish the two legal issues; it should not be counted as a sixth independent case.

Case 6: Hüls AG v Commission (1999)

Case C-199/92 P · Court of Justice of the European Communities

Principle: Presumption of innocence and evidentiary requirements in cartel proceedings.

The judgment is important for the relationship between participation in anti-competitive meetings, subsequent market conduct and the presumption of innocence.

Application to Moroccan vaccine tenders:

A competition authority must establish the infringement using legally sufficient evidence. It should not automatically presume that a vaccine manufacturer participated in bid rigging merely because:

It attended an industry meeting.

It operates in the same vaccine market.

Its prices resemble those of competitors.

It participated in previous government tenders.

The authority must establish the relevant anti-competitive conduct and the undertaking's responsibility while respecting procedural safeguards.

Overall significance: The six distinct precedents—T-Mobile Netherlands, Eturas, Verhuizingen Coppens, Anic Partecipazioni, Aalborg Portland and Hüls—provide comparative guidance on coordination, cover bidding, circumstantial evidence, cartel participation and procedural fairness.

6. Evidence Required to Establish Vaccine Tender Bid Rigging

An investigation into vaccine procurement should examine documentary, electronic, financial and commercial evidence.

A. Bid pattern analysis

Investigators should compare successive tenders to identify suspicious patterns.

For example:

Supplier A repeatedly wins tenders in one region.

Supplier B repeatedly wins another region.

Other suppliers submit consistently higher bids.

Winning positions rotate without an apparent commercial explanation.

B. Communication analysis

Investigators should examine communications between competing suppliers before and after tender announcements.

Particular attention should be given to communications containing proposed prices, tender strategies, confidential quantities and contract allocation arrangements.

C. Financial investigation

Payments between competing suppliers require careful examination where they have no legitimate commercial explanation.

For example, a distributor may receive compensation for withdrawing from a tender or submitting an intentionally uncompetitive offer.

D. Economic analysis

Authorities should compare bid prices against:

International vaccine prices.

Historical procurement prices.

Import and distribution costs.

Manufacturing costs where available.

Transportation and cold-chain expenses.

Market conditions and supply constraints.

A high price alone does not establish bid rigging.

7. Role of the Moroccan Competition Council

The Moroccan Competition Council plays an important role in protecting competitive markets.

Its responsibilities under the applicable competition framework include:

Investigating anti-competitive agreements.

Examining complaints concerning cartel behaviour.

Assessing agreements between pharmaceutical suppliers.

Investigating abuse of dominant position.

Examining market concentration where legally required.

Recommending or imposing appropriate competition-law measures within its statutory powers.

Investigative priorities

For vaccine procurement, the Council should examine:

Whether competing manufacturers coordinate tender prices.

Whether distributors divide geographical territories.

Whether suppliers manipulate bid participation.

Whether exclusive arrangements prevent alternative suppliers from entering the market.

Whether procurement procedures create opportunities for collusion.

Competition enforcement should also be coordinated, where legally appropriate, with procurement, public-health, pharmaceutical-regulatory and anti-corruption authorities.

8. Consequences and Legal Remedies

Bid rigging can create serious economic and public-health consequences.

A. Competition-law sanctions

Under Law No. 104-12, infringements of Article 6 and Article 7 may attract statutory financial penalties and other appropriate measures.

The consequences depend on the applicable statutory provisions, the seriousness of the infringement and the circumstances of the undertaking.

B. Procurement consequences

Depending on the applicable procurement rules and legal procedure, consequences may include:

Rejection of unlawful or non-compliant bids.

Suspension or cancellation of an affected procurement procedure.

Reassessment of the tender award.

Contractual remedies where legally available.

Exclusion or other procurement consequences where statutory conditions are satisfied.

C. Civil liability

Where unlawful collusion causes financial loss, affected parties may seek compensation under the applicable civil-law rules, subject to proof of:

Unlawful conduct.

Actual damage.

Causation.

The relevant legal requirements for liability.

D. Criminal and anti-corruption implications

Bid rigging may overlap with corruption, fraud, bribery or other criminal conduct.

However, a competition-law infringement does not automatically establish a criminal offence. Separate legal elements and procedural requirements must be satisfied.

9. Special Challenges in Vaccine Procurement

Vaccine procurement differs from ordinary commercial procurement because it involves public-health considerations.

A. Limited number of manufacturers

Some vaccines have only a small number of qualified manufacturers. This may create opportunities for coordination but does not itself prove collusion.

B. Regulatory requirements

Suppliers must satisfy applicable pharmaceutical authorisation, quality and safety requirements.

Tender criteria should not unnecessarily exclude qualified competitors.

C. Cold-chain infrastructure

Vaccines may require specialised refrigeration, transportation and storage.

Authorities must distinguish legitimate differences in logistics costs from artificial bid coordination.

D. Emergency procurement

Public-health emergencies may require accelerated procurement procedures.

Such procedures should remain subject to appropriate safeguards against collusion, conflicts of interest and unjustified preferential treatment.

E. Supply shortages

Genuine shortages can cause prices to rise and suppliers to prioritise particular buyers.

Investigators must distinguish independent commercial responses to shortages from agreements to manipulate availability or allocate contracts.

10. Prevention and Compliance Measures

Moroccan procurement authorities and pharmaceutical companies should adopt preventive measures to reduce the risk of vaccine tender collusion.

Recommended institutional measures

1. Procurement monitoring: Establish a monitoring mechanism to identify repeated winning patterns, identical pricing structures and suspicious bid withdrawals.

2. Competition compliance: Require pharmaceutical suppliers and distributors to adopt written competition-compliance policies.

3. Tender design: Avoid unnecessarily restrictive technical specifications that exclude qualified suppliers.

4. Independent evaluation: Ensure that tender committees operate independently and disclose conflicts of interest.

5. International cooperation: Cooperate with foreign competition authorities where international pharmaceutical groups or cross-border distribution arrangements are involved.

11. Illustrative Legal Scenario in Morocco

Consider a hypothetical government tender for supplying 1 million doses of a childhood vaccine.

Three pharmaceutical distributors participate:

Company A submits a bid of MAD 100 million.

Company B submits a bid of MAD 115 million.

Company C submits a bid of MAD 120 million.

The investigation subsequently discovers that the three companies communicated before the tender and agreed that Company A would win.

Company B and Company C deliberately submitted higher bids. In exchange, Company A promised to support Company B in a future regional procurement contract.

Legal assessment

Company A

Potential infringement

Participated in the agreed winning arrangement.

Company B

Potential infringement

Submitted a deliberately inflated cover bid.

Company C

Potential infringement

Participated in the agreed tender manipulation.

Applicable legal provision

Article 6 of Law No. 104-12, particularly its prohibition of agreements allocating public contracts and restricting competition.

If the evidence establishes the arrangement, the conduct could constitute bid rigging even if the government formally followed the tender procedure.

The authority would also examine whether the arrangement affected public expenditure, supplier access and vaccine availability.

12. Important Legal Distinctions

13. Conclusion

Competition Law in Vaccine Tender Bid Rigging in Morocco is an important area of pharmaceutical regulation, public procurement and economic governance.

Article 6 of Law No. 104-12 provides the central legal basis for addressing agreements between pharmaceutical suppliers that manipulate public vaccine procurement. Article 7 addresses abusive conduct by dominant vaccine manufacturers or distributors.

The comparative judgments in T-Mobile Netherlands, Eturas, Anic Partecipazioni, Aalborg Portland, Verhuizingen Coppens and Hüls provide useful principles for examining coordination, cover bidding, evidentiary standards and individual cartel responsibility.

Effective enforcement requires cooperation between the Moroccan Competition Council, procurement authorities, public-health institutions and pharmaceutical regulators.

Ultimately, the purpose of competition enforcement is not simply to reduce vaccine prices. It is to ensure that Morocco obtains safe, high-quality vaccines through fair procurement procedures, genuine supplier competition and reliable supply arrangements.

14. Key Legal Authorities for Further Study

Research qualification: The six judicial precedents are comparative authorities, not six Moroccan vaccine-tender judgments. The analysis applies Moroccan statutory provisions to a hypothetical vaccine procurement cartel and should not be mistaken for a finding that a particular Moroccan vaccine supplier has committed an infringement.